Immobilization of Chinese herbal medicine onto the surface-modified calcium hydrogenphosphate
Source abstract
Abstract
To accelerate the healing of bone defects or for healing to take place, it is often necessary to fill them with suitable substance. Various artificial materials defects have been developed. Among these, calcium phosphates and bioactive glass have been proven to be biocompatibile and bioactive materials that can chemically bond with bone, and have been successfully used clinically for repair of bone defects and augmentation of osseous tissue. However, those bioceramics have only the property of osteoconduction without any osteoinduction. Many ligands have been physicochemically absorbed onto substrates to enhance cell-substrate interactions. Although widely developed, they are still limited to use in long-term implantation because of their half-life period. Thus, some interfacial modification will be required for enhancing the efficacy of the delivery system. These models involve the immobilization of biologically active ligands of natural and synthetic origin onto various substrates to produce an interface with stronger chemical bond between ligand and substrate. The advantage of covalently immobilizing a ligand is that a chemical bond is present to prevent ligand or medicine from desorption. In our study, a two-step chemical immobilization was performed to surface-modified calcium hydrogenphosphate powders. The first was to modify the surface of calcium hydrogen-phosphate (CHP) with a coupling agent of hexanmethylene diisocyanate (HMDI). CHP surface modified by HMDI is abbreviated as MCHP. The linkage between CHP and HMDI will be characterized by FTIR. The second step was to immobilize chemically Gusuibu onto MCHP. Moreover, the sorption and desorption of Gusuibu was evaluated and quantitatively analyzed by spectrophotometer and HPLC. Bioceramic CHP was surface-modified by a two-step chemical immobilization. First, the surface of calcium hydrogen-phosphate (CHP) was successfully modified with coupling agent of hexanmethylene diisocyanate (HMDI). The first step was also activated the surface of CHP to induce primary amine terminator. The reaction of this functional group with Gusuibu was the second step. We confirmed simultaneously that Gusuibu could be immobilized chemically onto the surface of MCHP. Although some immobilized Gusuibu was also released rapidly at the first 12h, the degree of the released Gusuibu was lower than both by Gusuibu-adsorbing MCHP and Gusuibu-adsorbing CHP.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · 3D Printing in Biomedical Research · Bone Metabolism and Diseases
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (35)
Show source-provided references
1. Perforated demineralized bone matrix10.1002/jbm.820200603 ↗
2. Bioceramics10.1097/00003086-199012000-00018 ↗
3. Bone bonding behavior of MgO-CaO-SiO2-P2O5 glass10.1002/jbm.820230607 ↗
4. Formation of calcium phosphate films on silicate glasses10.1016/0022-3093(80)90514-1 ↗
5. Behavior of fetal rat osteoblasts cultured in vitro on the DP-bioactive glass substratum10.1016/S0254-0584(97)80174-5 ↗
6. Evaluation of a novel malleable, biodegradable osteoconductive composite in a rabbit cranial defect model10.1016/S0254-0584(98)00049-2 ↗
7. Adsorption and release of insulin-like growth factor-I on porous tricalcium phosphate implant10.1002/(SICI)1097-4636(20000305)49:3<415::AID-JBM15>3.0.CO;2-Z ↗
8. In vitro sorption and desorption of basic fibroblast growth factor from biodegradable hydrogels10.1016/S0142-9612(98)00089-1 ↗
9. Vascularization effect of basic fibroblast growth factor released from gelatin hydrogels with different biodegradabilities10.1016/S0142-9612(99)00121-0 ↗
10. Human osteoblast response in vitro to platelet-derived growth factor and transforming growth factor-β delivered from controlled-release polymer rods10.1016/S0142-9612(97)00049-5 ↗
11. Development of tricalcium phosphate/amylopectin paste combined with recombinant human transforming growth factor beta 1 as a bone defect filler10.1002/(SICI)1097-4636(19970905)36:3<295::AID-JBM4>3.0.CO;2-9 ↗
12. Ceramic hydroxyapatite implants for the release of bisphosphonate10.1016/S0169-6009(08)80254-1 ↗
13. Examination by X-ray pho-toelectron spectroscopy of the adsorption of chlorhexidine on hydroxyapatite10.1177/00220345920710080601 ↗
14. In vitro drug release of antibiotic-loaded porous hy-droxyapatite cement10.3109/10731199509117669 ↗
15. Application of hydroxyapatite-sol as drug carrier
16. Self-setting hydroxyapatite cement10.1002/jps.2600810611 ↗
17. Calcium hydroxyapatite ceramic used as a delivery system for antibiotics10.1302/0301-620X.74B4.1320622 ↗
18. A novel skeletal drug-delivery system using self-setting calcium phosphate cement. 3. Physicochemical properties and drug release rate of bovine insulin and bovine albumin10.1002/jps.2600830229 ↗
19. A novel skeletal drug delivery system using self-setting calcium phosphate cement. 4. Effects of the mixing solution volume on the drug-release rate of heterogeneous aspirin-loaded cement10.1002/jps.2600830230 ↗
20. Ceramic systems for long-term de-livery of chemicals and biologicals10.1002/jbm.820221212 ↗
21. Development of a hydroxyapatite ceramic matrix for the continuous delivery of coumadin
22. Slow release of anticancer drugs from porous calcium hydroxyapatite ceramic10.1002/jor.1100100317 ↗
23. A novel skeletal drug delivery system using self-setting calcium phosphate cement. 5. Drug release behaviour from a heterogenous drug-loaded cement containing an anticancer drug10.1002/jps.2600831109 ↗
24. A novel skeletal drug delivery system using self-setting calcium phosphate cement. 7. Effect of biological factors on indometh-acin release from the cement loaded on bovine bone10.1002/jps.2600831110 ↗
25. Controlled release of hydrophilic compounds by resorbable and biodegradable ce-ramic drug delivery devices
26. Continuous delivery of azidothymidine by hydroxyapatite or tricalcium phosphate ceramics
27. A study on grafting and characterization of HMDI-modified calcium hydrogenphosphate10.1016/S0142-9612(01)00070-9 ↗
28. Stimulative effects of gusuibu (Drynaria baronii) injection on chick embryo bone primordium calcification in vitro. Chung-Kuo Chung Yao Tsa Chih-China
29. Therapeutic effect of Drynaria baronii Diels on experimental osteoarthritis
30. Stimulative effects of gusuibu (Drynaria baronii) injection on chick embryo bone primordium calcification in vitro10.1142/S0192415X96000104 ↗
31. A flavanol glycoside from Drynaria propinqua10.1016/S0031-9422(00)86903-4 ↗
32. Studies on the chemical constituents of Drynaria propinqua (wall)
33. Original plants and their taxonomic studies of crude drug Gusuibu
34. Identification and determination of Flavonoids in Twelve types of Gusuibu (Rhizoma Drynariae)
35. Quality evaluation of 3 kinds of rhizoma Drynariae